Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag v3.6.4 appears on the page, replacing the previous v3.6.3 to reflect a minor site update.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3. This indicates a newer release of the page template or rendering tooling used to present the study record.SummaryDifference0.0%

- Check48 days agoChange DetectedRecruitment status updated to no longer recruit; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was standardized, and the page revision tag was updated to v3.6.0.SummaryDifference0.4%

- Check55 days agoChange DetectedPage revision changed from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata. This update does not alter the study content or user-facing functionality.SummaryDifference0.0%

- Check77 days agoChange DetectedThe revision tag on the page updated from v3.5.3 to v3.5.4, signaling a minor backend update to the page. The visible content and user-facing information remain unchanged.SummaryDifference0.0%

- Check98 days agoChange DetectedThe page’s site revision label updated from **v3.5.2** to **v3.5.3** at the bottom of the ClinicalTrials.gov study page.SummaryDifference0.0%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.